1 code implementation • 24 Dec 2019 • Yanxing Wang, Jianxing Hu, Junyong Lai, Yibo Li, Hongwei Jin, Lihe Zhang, Liangren Zhang, Zhenming Liu
Molecular fingerprints are the workhorse in ligand-based drug discovery.
no code implementations • 20 Aug 2019 • Yibo Li, Jianxing Hu, Yanxing Wang, Jielong Zhou, Liangren Zhang, Zhenming Liu
Furthermore, the generated compounds were evaluated by molecular docking in DRD2 targets and the results demonstrated that this approach can be effectively applied to solve several drug design problems, including the generation of compounds containing a given scaffold and de novo drug design of potential drug candidates with specific docking scores.